12.14.2018

Silvia Davi

12.14.2018

As Chief Marketing and Corporate Communications Officer of Symbiont, a technology pioneer solving complex global finance problems using enterprise blockchain solutions, Silvia Davi oversees all aspects of global marketing, brand, corporate communications, public affairs, digital communications, investor relations and social responsibility.

Silvia’s expertise stems from international communications agencies, in-house publicly traded Fortune 500 corporations, start-ups, and nonprofits. She has held leadership roles at respected financial and professional services firms including Nasdaq, Instinet, Marsh & McLennan, and Edelman.

More recently, she has worked with numerous fast-paced fintechs such as Thesys Technologies and 280 CapMarkets, now InspereX from start-up to exit on brand-building, corporate development and communications growth strategies. Silvia currently serves on the Board of Directors for national non-profit Tuesday’s Children and various industry Advisory Boards such as The Museum of American Finance (MOAF).

 

Newsletter sign up

A recent Markets Media article highlights how @tZERO is resetting its vision - focusing on partnerships, regulated infrastructure, and global scale to make tokenized capital markets a reality.

Under CEO @Alan_Konevsky, the company is leveraging regulatory momentum to enable…

Want to know who calls the shots on trading tech? We partnered with @WeAreAdaptive to interview capital markets professionals globally to uncover key trends and evolving patterns in technology deployment. Reach the report here:

Load More

Related articles

We're Enhancing Your Experience with Smart Technology

We've updated our Terms & Conditions and Privacy Policy to introduce AI tools that will personalize your content, improve our market analysis, and deliver more relevant insights.These changes take effect on Aug 25, 2025.
Your data remains protected—we're simply using smart technology to serve you better. [Review Full Terms] | [Review Privacy Policy] Please review our updated Terms & Conditions and Privacy Policy carefully. By continuing to use our services after Aug 25, 2025, you agree to these

Close the CTA